lung adenocarcinoma tissues; adjacent tissues; tumor tissues
SPC-A-1; H1975; A549; H1299
cell line-derived xenograft
proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); ceRNA regulation (promotes)
RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Clinical Sample Validation; Nuclear-Cytoplasmic Fractionation; Luciferase Reporter Assay; Transfection; EdU Staining; Transwell Assay; In Vivo Animal Model; Western Blot; Survival Analysis; Bioinformatics Analysis
Elevated hsa_circ_0001588 expression was associated with tumor size, lymphatic metastasis, distant metastasis, shorter survival time, poor clinicopathological features, and adverse prognosis; hsa_circ_0001588 may be an underlying therapeutic target for lung adenocarcinoma.
hsa_circ_0001588 is upregulated in lung adenocarcinoma tissues and cell lines and high expression is associated with poor clinicopathological features and adverse prognosis. Functionally, it promotes proliferation, migration, invasion, metastasis, and in vivo tumor growth. Mechanistically, cytoplasmic hsa_circ_0001588 acts as a ceRNA for miR-524-3p to increase NACC1 expression, supporting its potential as a therapeutic target.
0.8162
Circular RNA hsa_circ_0001588 promotes the malignant progression of lung adenocarcinoma by modulating miR-524-3p/NACC1 signaling.
combined biological and clinical study